Tat-Beclin 1 Proteins
We offer Tat-Beclin 1 Peptides and Tat-Beclin 1 Proteins for use in common research applications: Functional, In vitro assay, In vivo assay. Each Tat-Beclin 1 Peptide and Tat-Beclin 1 Protein is fully covered by our Guarantee+, to give you complete peace of mind and the support when you need it. Our Tat-Beclin 1 Peptides and Tat-Beclin 1 Proteins can be used in a variety of model species. Use the list below to choose the Tat-Beclin 1 Peptide and Tat-Beclin 1 Protein which is most appropriate for your research; you can click on each one to view full technical details, images, references, reviews and related products. Choose from our Tat-Beclin 1 Peptides and Proteins.
Alternate Names for Tat-Beclin 1 Proteins
Autophagy Inducing peptide protein, Tat-Beclin 1 peptide protein, Tat-Beclin peptide protein, Tat-Beclin protein
3 Results for "tat-beclin-1" in Peptides and Proteins
![Immunocytochemistry/Immunofluorescence: Tat-Beclin 1 D11 Autophagy Inducing Peptide [NBP2-49888] - HeLa GFP-LC3B cells were treated with Tat-D11, Tat-L11, Tat-Beclin 1 or Tat-L11S for 1.5 hours. Thereafter, the cells were stained using NeuroTrace Red or DAPI and analyzed employing fluorescent microscopy. Note the higher number of autophagosomes/GFP-LC3B+ puncta in the images of Tat-D11 and Tat-L11 treated cells when compared to Tat-Beclin 1 and Tat-L11S treated cells.](http://images.novusbio.com/fullsize/Tat-Beclin-1-D11-Autophagy-Inducing-Peptide-Immunocytochemistry-Immunofluorescence-NBP2-49888-img0002.jpg "Immunocytochemistry/Immunofluorescence: Tat-Beclin 1 D11 Autophagy Inducing Peptide [NBP2-49888] - HeLa GFP-LC3B cells were treated with Tat-D11, Tat-L11, Tat-Beclin 1 or Tat-L11S for 1.5 hours. Thereafter, the cells were stained using NeuroTrace Red or DAPI and analyzed employing fluorescent microscopy. Note the higher number of autophagosomes/GFP-LC3B+ puncta in the images of Tat-D11 and Tat-L11 treated cells when compared to Tat-Beclin 1 and Tat-L11S treated cells.")
![In vitro assay: Tat-Beclin 1 D11 Autophagy Inducing Peptide - Retroinverso form [NBP2-49888] - Analysis of lysates from HeLa cells that were left untreated (blank) or were treated with 10-20 uM each of Tat-D11, Tat-L11, Tat-Beclin 1 or Tat-L11S. The lysates were analyzed for the expression of LC3-1/LC3-II and SQSTM1/p62 using 2 ug/mL each of anti-LC3B (NB100-2220) and anti-SQSTM1/p62 (MAB8028) respectively. Anti-Actin (AF4000) was used as a loading control. TatD11 exhibited superior induction of LC3-II and down-regulation of p62 protein when compared to other treatment and control groups.](http://images.novusbio.com/fullsize/Tat-Beclin-1-D11-Autophagy-Inducing-Peptide---Retroinverso-form-Western-Blot-NBP2-49888-img0001.jpg)
![In vivo assay: Tat-Beclin 1 D11 Autophagy Inducing Peptide - Retroinverso form [NBP2-49888] - In vivo dose study in 10wk old C57BL/6J mice. Either 1mg/kg or 10mg/kg IP once daily was administered for 2 days, mice were sacrificed, kidneys prepared for Western blot analysis. Lysosomal inhibitor bafilomycin A1 was used to provide a measurement of autophagic flux. *vehicle is scrambled tat-beclin (NBP2-49887-5mg). Image from verified customer review.](http://images.novusbio.com/fullsize/Tat-Beclin-1-D11-Autophagy-Inducing-Peptide---Retroinverso-form-In-vivo-assay-NBP2-49888-img0004.jpg)
![Western Blot: Tat-Beclin 1 L11S Autophagy Inducing Peptide - Inactive Form [NBP2-49887] - WB analysis of lysates from HeLa cells that were left untreated (blank) or were treated with 10-20 uM each of Tat-D11, Tat-L11, Tat-Beclin 1 or Tat-L11S. The lysates were analyzed for the expression of LC3-1/LC3-II and SQSTM1/p62 using 2ug/ml each of anti-LC3B (NB100-2220) and anti-SQSTM1/p62 (MAB8028) respectively. Anti-Actin (AF4000) was used as a loading control. TatD11 exhibited superior induction of LC3-II and down-regulation of p62 protein when compared to other treatment and control groups.](http://images.novusbio.com/fullsize/Tat-Beclin-1-L11S-Autophagy-Inducing-Peptide---Inactive-Form-Western-Blot-NBP2-49887-img0001.jpg "Western Blot: Tat-Beclin 1 L11S Autophagy Inducing Peptide - Inactive Form [NBP2-49887] - WB analysis of lysates from HeLa cells that were left untreated (blank) or were treated with 10-20 uM each of Tat-D11, Tat-L11, Tat-Beclin 1 or Tat-L11S. The lysates were analyzed for the expression of LC3-1/LC3-II and SQSTM1/p62 using 2ug/ml each of anti-LC3B (NB100-2220) and anti-SQSTM1/p62 (MAB8028) respectively. Anti-Actin (AF4000) was used as a loading control. TatD11 exhibited superior induction of LC3-II and down-regulation of p62 protein when compared to other treatment and control groups.")
![Immunocytochemistry/Immunofluorescence: Tat-Beclin 1 L11S Autophagy Inducing Peptide - Inactive Form [NBP2-49887] - HeLa GFP-LC3B cells were treated with Tat-D11, Tat-L11, Tat-Beclin 1 or Tat-L11S for 1.5 hours. Thereafter, the cells were stained using NeuroTrace Red or DAPI and analyzed employing fluorescent microscopy. Note the higher number of autophagosomes/GFP-LC3B+ puncta in the images of Tat-D11 and Tat-L11 treated cells when compared to Tat-Beclin 1 and Tat-L11S treated cells.](http://images.novusbio.com/fullsize/Tat-Beclin-1-L11S-Autophagy-Inducing-Peptide---Inactive-Form-Immunocytochemistry-Immunofluorescence-NBP2-49887-img0002.jpg)
![In vivo assay: Tat-Beclin 1 L11S Peptide - Scrambled Control [NBP2-49887] - In vivo dose study in mouse kidneys as control for tat-beclin D11 autophagy inducing peptide. Well tolerated by mice at dose of 1mg/kg for 2 days IP. Soluble in PBS. First two lanes (controls) are treated with 1mg/kg tat-beclin scrambled peptide; remaining lanes are treated with tat-beclin D11 autophagy inducing peptide. Image from verified customer review.](http://images.novusbio.com/fullsize/Tat-Beclin-1-L11S-Peptide---Scrambled-Control-In-vivo-assay-NBP2-49887-img0003.jpg)
![Western Blot: Tat-Beclin 1 L11 Autophagy Inducing Peptide [NBP2-49886] - WB analysis of lysates from HeLa cells that were left untreated (blank) or were treated with 10-20 uM each of Tat-D11, Tat-L11, Tat-Beclin 1 or Tat-L11S. The lysates were analyzed for the expression of LC3-1/LC3-II and SQSTM1/p62 using 2ug/ml each of anti-LC3B (NB100-2220) and anti-SQSTM1/p62 (MAB8028) respectively. Anti-Actin (AF4000) was used as a loading control. TatD11 exhibited superior induction of LC3-II and down-regulation of p62 protein when compared to other treatment and control groups.](http://images.novusbio.com/fullsize/Tat-Beclin-1-L11-Autophagy-Inducing-Peptide-Western-Blot-NBP2-49886-img0001.jpg "Western Blot: Tat-Beclin 1 L11 Autophagy Inducing Peptide [NBP2-49886] - WB analysis of lysates from HeLa cells that were left untreated (blank) or were treated with 10-20 uM each of Tat-D11, Tat-L11, Tat-Beclin 1 or Tat-L11S. The lysates were analyzed for the expression of LC3-1/LC3-II and SQSTM1/p62 using 2ug/ml each of anti-LC3B (NB100-2220) and anti-SQSTM1/p62 (MAB8028) respectively. Anti-Actin (AF4000) was used as a loading control. TatD11 exhibited superior induction of LC3-II and down-regulation of p62 protein when compared to other treatment and control groups.")
![Immunocytochemistry/Immunofluorescence: Tat-Beclin 1 L11 Autophagy Inducing Peptide [NBP2-49886] - HeLa GFP-LC3B cells were treated with Tat-D11, Tat-L11, Tat-Beclin 1 or Tat-L11S for 1.5 hours. Thereafter, the cells were stained using NeuroTrace Red or DAPI and analyzed employing fluorescent microscopy. Note the higher number of autophagosomes/GFP-LC3B+ puncta in the images of Tat-D11 and Tat-L11 treated cells when compared to Tat-Beclin 1 and Tat-L11S treated cells.](http://images.novusbio.com/fullsize/Tat-Beclin-1-L11-Autophagy-Inducing-Peptide-Immunocytochemistry-Immunofluorescence-NBP2-49886-img0002.jpg)